SMTL ID : 7s5h.1

PCSK9(deltaCRD) in complex with cyclic peptide 35

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.27 Å

Oligo State

hetero-1-1-mer

Ligands

1 x Z50- DNP- DAL- PHE- FTR- PRO- THR- 0A1- 3WX: Z50-DNP-DAL-PHE-FTR-PRO-THR-0A1-3WX(Non-covalent)

Z50-DNP-DAL-PHE-FTR-PRO-THR-0A1-3WX.1: 13 residues within 4Å: Chain B: D.86, A.87, D.215, I.217, S.220, D.222, C.223, T.225, C.226, F.227, V.228, S.229 Ligands: 89N.2 14 PLIP interactions: 14 interactions with chain B Hydrophobic interactions: B:D.86, B:A.87, B:I.217, B:D.222, B:F.227, B:V.228 Hydrogen bonds: B:T.225, B:F.227, B:F.227, B:S.229, B:S.229, B:S.229 Water bridges: B:T.225 pi-Stacking: B:F.227

1 x 89N: (2E)-but-2-ene-1,4-diol(Non-covalent)

89N.2: 4 residues within 4Å: Chain B: C.226 Ligands: Z50-DNP-DAL-PHE-FTR-PRO-THR-0A1-3WX.1, Z50-DNP-DAL-PHE-FTR-PRO-THR-0A1-3WX.1, Z50-DNP-DAL-PHE-FTR-PRO-THR-0A1-3WX.1 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Tucker, T.J. et al., A Series of Novel, Highly Potent, and Orally Bioavailable Next-Generation Tricyclic Peptide PCSK9 Inhibitors. J.Med.Chem. (2021)

Release Date

2021-11-03

Peptides

Pro-peptide from Proprotein convertase subtilisin/kexin type 9: A
Proprotein convertase subtilisin/kexin type 9: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Pro-peptide from Proprotein convertase subtilisin/kexin type 9

Proprotein convertase subtilisin/kexin type 9

Related Entries With Identical Sequence